Semler Scientific (NASDAQ:SMLR) Trading 6.6% Higher – Time to Buy?

Semler Scientific, Inc. (NASDAQ:SMLR)’s stock price traded up 6.6% during mid-day trading on Wednesday . The stock traded as high as $64.28 and last traded at $63.79. 199,612 shares changed hands during mid-day trading, a decline of 27% from the average session volume of 273,106 shares. The stock had previously closed at $59.83.

Semler Scientific Stock Down 6.5 %

The company has a market cap of $556.77 million, a P/E ratio of 32.40 and a beta of 1.18. The stock has a 50 day moving average price of $42.98 and a two-hundred day moving average price of $34.45.

Semler Scientific (NASDAQ:SMLR) last announced its earnings results on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.35. The company had revenue of $13.51 million for the quarter. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.

Institutional Investors Weigh In On Semler Scientific

A number of large investors have recently modified their holdings of the business. Sanctuary Advisors LLC acquired a new stake in shares of Semler Scientific in the 3rd quarter valued at $104,000. Geode Capital Management LLC boosted its holdings in shares of Semler Scientific by 10.5% in the 3rd quarter. Geode Capital Management LLC now owns 135,959 shares of the company’s stock valued at $3,202,000 after purchasing an additional 12,964 shares in the last quarter. Jane Street Group LLC boosted its holdings in shares of Semler Scientific by 72.3% in the 3rd quarter. Jane Street Group LLC now owns 16,982 shares of the company’s stock valued at $400,000 after purchasing an additional 7,126 shares in the last quarter. State Street Corp boosted its holdings in shares of Semler Scientific by 0.6% in the 3rd quarter. State Street Corp now owns 118,223 shares of the company’s stock valued at $2,784,000 after purchasing an additional 725 shares in the last quarter. Finally, Verition Fund Management LLC acquired a new stake in shares of Semler Scientific in the 3rd quarter valued at $251,000. Institutional investors and hedge funds own 49.37% of the company’s stock.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.